<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01231789</url>
  </required_header>
  <id_info>
    <org_study_id>RIPC-Cardiac-Neuroprotection</org_study_id>
    <nct_id>NCT01231789</nct_id>
  </id_info>
  <brief_title>The Neuroprotection of Remote Ischemic Preconditioning (RIPC) on Cardiac Surgery in Multicenter</brief_title>
  <official_title>The Neuroprotection of Remote Ischemic Preconditioning on Cardiac Surgery in Multicenter</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study is designed to clarify the neuroprotective effect of remote ischemic&#xD;
      preconditioning on the patients underwent open-heart cardiac surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND: Brain ischemia and injury are commonly contributed to perioperative morbidity and&#xD;
      mortality after cardiac surgery. Remote ischemic preconditioning (RIPC) is a phenomenon&#xD;
      whereby brief periods of ischemia followed by reperfusion in one organ provide systemic&#xD;
      protection from prolonged ischemia. To investigate whether remote preconditioning protects&#xD;
      the brain injury in patients undergoing elective cardiac surgery, a randomized trial will be&#xD;
      performed in current study.&#xD;
&#xD;
      DESIGNING 150 patients will be randomize assigned to cardiac surgery with RIPC or without&#xD;
      RIPC (control). Remote ischemic preconditioning consist of three 5-min cycles of right upper&#xD;
      limb ischaemia, induced by an automated cuff-inflator placed on the upper arm and inflated to&#xD;
      200 mm Hg, with an intervening 5 min of reperfusion during which the cuff is deflated.&#xD;
      Cerebral injury was assessed by S-100b, NSE, and neurological function scores in different&#xD;
      time points.&#xD;
&#xD;
      EXPECTED RESULTS RIPC will reduce the incidence of cerebral injury in cardiac surgery.&#xD;
&#xD;
      CONCLUSIONS:&#xD;
&#xD;
      In patients undergoing elective cardiac surgery, RIPC reduces the incidence of postoperative&#xD;
      cerebral injury.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2009</start_date>
  <completion_date type="Anticipated">August 2013</completion_date>
  <primary_completion_date type="Anticipated">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the neurological injury markers, including serum level of S-100B and NSE</measure>
    <time_frame>before surgery, 6h, 24h, 48h, and 72h after bypass</time_frame>
    <description>the biomarkers of brain injury</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>mini-mental state examination scale</measure>
    <time_frame>6 months after surgery</time_frame>
    <description>the neurological function</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Cardiac Surgery Patients</condition>
  <arm_group>
    <arm_group_label>sham RIPC</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Patients had a deflated cuff placed on the right upper arm for 30 min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RIPC treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>RIPC consisted of three 5-min cycles of right upper arm ischemia, which was induced by an automated cuff-inflator placed on the right upper arm and inflated to 200 mmHg, with an intervening 5 min of reperfusion during which the cuff was deflated</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>RIPC</intervention_name>
    <description>RIPC consisted of three 5-min cycles of right upper arm ischemia, which was induced by an automated cuff-inflator placed on the right upper arm and inflated to 200 mmHg, with an intervening 5 min of reperfusion during which the cuff was deflated</description>
    <arm_group_label>RIPC treatment</arm_group_label>
    <other_name>remote ischemic preconditioning</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sham RIPC</intervention_name>
    <description>Patients had a deflated cuff placed on the right upper arm for 30 min without any inflation procedure.</description>
    <arm_group_label>sham RIPC</arm_group_label>
    <other_name>sham remote ischemic preconditioning</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients diagnosed with acquired heart valve diseases scheduled for valve replacement&#xD;
             or CABG&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Were unable to give informed consent&#xD;
&#xD;
          -  Patients who presented with other systemic diseases such as hepatic,renal, and&#xD;
             pulmonary diseases, or have had a heart operation before, were excluded.&#xD;
&#xD;
          -  Additionally, patients taking antidiabetic sulfonylurea or glibenclamide were excluded&#xD;
             because these agents have been shown to abrogate the cardioprotection elicited by&#xD;
             ischemic preconditioning.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hailong Dong, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xijing Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hailong DONG, MD, PhD</last_name>
    <phone>86-2984775337</phone>
    <email>hldong6@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xijing Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hailong Dong, MD,PhD</last_name>
    </contact>
    <investigator>
      <last_name>Hailong Dong, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2009</verification_date>
  <study_first_submitted>September 15, 2010</study_first_submitted>
  <study_first_submitted_qc>October 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2010</study_first_posted>
  <last_update_submitted>August 19, 2012</last_update_submitted>
  <last_update_submitted_qc>August 19, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 21, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cardiac surgery</keyword>
  <keyword>RIPC</keyword>
  <keyword>brain injury</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

